CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation Feb 29, 2024 | Uncategorized
Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells Jul 20, 2023 | Uncategorized
Intra-Tumor Injection of CAR-Engineered NK Cells Induces Tumor Regression and Protection Against Tumor Re-Challenge Jul 10, 2023 | Uncategorized
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele Jul 10, 2023 | Uncategorized
